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Abstract Influenza virus replication has been effectively
inhibited by antisense phosphothioate oligonucleotides targeting
the AUG initiation codon of PB2 mRNA. We designed RNA-
cleaving DNA enzymes from 10-23 catalytic motif to target
PB2-AUG initiation codon and measured their RNA-cleaving
activity in vitro. Although the RNA-cleaving activity was not
optimal under physiological conditions, DNA enzymes inhibited
viral replication in cultured cells more effectively than antisense
phosphothioate oligonucleotides. Our data indicated that
DNA enzymes could be useful for the control of viral
infection. ß 2000 Federation of European Biochemical Soci-
eties. Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
Antisense oligonucleotides have been widely used for the
speci¢c inhibition of gene expression. They were developed
rapidly as therapeutic agents and soon moved from the labo-
ratory into the clinical ¢eld [1^3]. When the administration of
large amounts of antisense phosphothioate oligonucleotides is
required, however, there is usually a toxicity problem [1].
Recently, general-purpose RNA-cleaving DNA enzymes
have been developed and two catalytic motifs, 10-23 and 8-
17, were reported [4,5]. These DNA enzymes are catalytic in
nature and can be engineered to cleave a target gene in trans
in a sequence-speci¢c manner. The ¢rst antiviral application
of DNA enzymes was in the inhibition of human immunode-
¢ciency virus (HIV) [6^8]. Although DNA enzymes were
shown to inhibit HIV infection, they have yet to be utilized
to inhibit viral infections in general.
To date, the application of antisense phosphothioate oligo-
nucleotides to inhibit the replication of various viruses has
been of great success [1]. We have demonstrated that lipo-
some-encapsulated antisense phosphothioate oligonucleotides
complementary to PB2-AUG and PA-AUG initiation codons
inhibited the in£uenza virus RNA polymerase activity [9^11],
and in£uenza virus replication in MDCK cells [12^14] and in
mice [15]. In this paper, we describe the inhibition of in£uenza
virus replication in cultured cells by RNA-cleaving DNA en-
zyme which was designed from 10-23 catalytic motif targeting
the PB2-AUG initiation codon, and compare the results with
those for antisense phosphothioate oligonucleotides comple-
mentary to the same position [15].
2. Materials and methods
2.1. DNA enzymes targeting the in£uenza virus A/PR8/34 PB2 subunit
Based on Santoro and Joyce’s reports [4,5], we designed RNA-
cleaving DNA enzymes to target the translation initiation codon of
PB2 mRNA (Table 1). 10-23 DNA enzyme sequence was £anked with
two antisense sequences (7 or 8 nucleotides (nt)). As a control, a 16 nt
random sequence was £anked with each 8 nt antisense sequence of
PB2 mRNA.
2.2. Cells and viruses
MDBK and MDCK cells were grown in Dulbecco’s modi¢ed Ea-
gle’s medium supplemented with 5% fetal bovine serum. In£uenza
virus A/PR8/34 was grown in 11-day-old embryonated chicken eggs
at 34‡C for 48 h, and stored at 380‡C until used.
2.3. In vitro RNA synthesis and cleavage of PB2 transcript by DNA
enzyme
T7 promoter sequences were tagged at the 5P-termini of PB2 and
PB1 cDNA, respectively. PB2 plasmid, pAPR102 [16], was PCR-
ampli¢ed using KOD polymerase (Toyobo) and primer 5P-GTC-
GACTCTAGAGGATCCTAATACGACTCACTATAAGCGAAA-
GCAGGTCAATTAT-3P and 5P-AGTAGAAACAAGGTCGTTTT-
3P. PB1 plasmid, pAPR206 [16], was PCR-ampli¢ed using KOD poly-
merase (Toyobo) and primer 5P-GTCGACTCTAGAGGATCCTAA-
TACGACTCACTATAAGCGAAAGCAGGCAAACCAT-3P and 5P-
AGTAGGAACAAGGCATTTTT-3P. The ampli¢ed fragments were
digested with XbaI and inserted between XbaI and SmaI sites of
pUC19, resulting in pT7cPB2 and pT7cPB1. [32P]UMP-labeled posi-
tive sense RNA fragments of PB2 and PB1 were transcribed in vitro
using T7 RNA polymerase (Toyobo, 15 U) and 1 Wg of pT7cPB2
digested with NdeI (109 nt) and pT7cPB1 digested with NcoI
(121 nt) as templates in 40 mM Tris^HCl, pH 7.5, 6 mM MgCl2,
2 mM spermidine, 10 mM NaCl, 10 mM dithiothreitol, 0.5 mM
each of ATP, CTP, GTP, 50 WM UTP and 50 WCi [K-32P]UTP (Amer-
sham). The transcribed 32P-labeled RNA was puri¢ed by 6% poly-
acrylamide gel electrophoresis/7 M urea.
10 nmol of 32P-labeled RNA substrate was incubated with 1 WM of
DNA enzyme in various conditions as indicated in the text.
2.4. Inhibition of in£uenza virus replication by DNA enzyme
Subcon£uent MDBK cells on 48-well plates were washed three
times with phosphate-bu¡ered saline and inoculated with in£uenza
virus A/PR8/34 at a multiplicity of infection (moi) of 0.1 (unless
otherwise indicated) at 4‡C for 1 h, and then transfected with the
indicated amount of oligonucleotides, DNA enzymes or antisense
thio-oligonucleotides (ODN PB2as (20), ODN PB2ran (20), ODN
PB2as (28) and ODN PB2ran (28)), in OPTI-MEM I (Lifetech Ori-
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ental) containing 2% lipofectin (Lifetech Oriental) at 34‡C for 4 h [15].
After transfection, cells were further incubated in MEM containing
0.1% bovine serum albumin (BSA) and 2 Wg/ml of trypsin (Difco) at
34‡C for 20 h. The cells were harvested and the titer of the viruses was
measured by plaque-forming assay on MDCK cells after three cycles
of freezing and thawing. Con£uent MDCK cells on 12-well plates
were inoculated with serial dilutions of the viruses at 25‡C for 1 h,
and then overlaid with MEM containing 0.8% agarose, 5 Wg/ml tryp-
sin and 0.1% BSA [17]. After 2 days incubation at 34‡C, the cells were
¢xed with ethanol:acetic acid (5:1) and stained with 0.1% amide
black.
3. Results
3.1. Sequence-speci¢c cleavage by DNA enzyme
First, the sequence-speci¢c cleavage by DNA enzyme,
DNzPB2 (14), DNzPB2 (16) and the control DNA enzyme
which did not carry the catalytic sequence of 10-23, DNzPB2
(C), was examined using PB2 and PB1 transcripts. 10 nmol
substrate RNA was incubated with 1 WM DNA enzyme or
antisense phosphothioate oligonucleotides (Fig. 1). In these
conditions, DNzPB2 (16) cleaved PB2 transcript more e⁄-
ciently than DNzPB2 (14). Neither DNzPB2 (14) nor
DNzPB2 (16) cleaved PB1 transcript at all. DNzPB2 (C) or
antisense phosphothioate oligonucleotides (ODN PB2as (20)
and ODN PB2as (28)) did not cleave any RNA substrates at
all.
Next, the e¡ect of concentration of MgCl2 on RNA-
cleaving activity was examined using DNA enzyme with a
16 nt complementary sequence to PB2 mRNA, DNzPB2
(16). 32P-labeled PB2 transcript (10 nmol) and 1 WM DNzPB2
(16) were incubated in 0, 1, 2, 5, 10, 20, 50, 100, 200 or 500 M
MgCl2, 30 mM HEPES/NaOH, pH 7.6, and 150 mM NaCl at
37‡C for 1 h (Fig. 2A). No cleavage occurred without MgCl2.
The most e⁄cient cleavage was observed at 100 mM MgCl2.
The e⁄ciency of cleavage did not increase when the MgCl2
concentration was more than 200 mM.
However, the concentration of NaCl little a¡ected the
cleavage e⁄ciency. PB2 transcript (10 nmol) and 1 WM
DNzPB2 (16) were incubated in 0, 20, 100, 200, 300, 400,
500 or 1000 mM NaCl, 30 mM HEPES/NaOH, pH 7.6, and
20 mM MgCl2 at 37‡C for 1 h (Fig. 2B). The e⁄ciency of
cleavage was similar at NaCl concentrations less than 200 mM,
and it increased according to the NaCl concentration at more
than 300 mM.
The e¡ect of pH was examined. PB2 transcript (10 nmol)
and 1 WM DNzPB2 (16) were incubated in 50 mM sodium
citrate (pH 4 and pH 5), 50 mM MES/NaOH (pH 6), 50 mM
Fig. 1. Sequence-speci¢c cleavage by DNA enzymes. The sequence-
speci¢c cleavage by DNA enzyme, DNzPB2 (14) (lanes 1 and 6),
DNzPB2 (16) (lanes 2 and 7) and the control oligodeoxynucleotide
DNzPB2 (C) (lanes 3 and 8) was examined using PB2 (lanes 1^5)
and PB1 transcripts (lanes 6^10). 10 nmol substrate RNA was incu-
bated with 1 WM DNA enzyme or antisense phosphothioate oligo-
nucleotides (ODN PB2as (20), lanes 4 and 9; ODN PB2as (28),
lanes 5 and 10). The positions of substrate RNAs (PB1 and PB2)
and the cleaved products of PB2 (P1 and P2) are indicated by ar-
rowheads.
Fig. 2. In vitro cleavage by DNA enzymes. The e¡ect of MgCl2 concentration (A), NaCl concentration (B), pH (C), incubation temperature
(D) and incubation time (E) was examined in vitro as described in Sections 2 and 3. The average % cleavage and the standard deviation were
calculated from two independent experiments and plotted in the graph.
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HEPES/NaOH (pH 7, pH 7.5 and pH 8), 50 mM CHES/
NaOH (pH 9) and 50 mM CAPS/NaOH (pH 10) in the pres-
ence of 20 mM MgCl2 and 150 mM NaCl, at 37‡C for 1 h.
The highest cleavage was achieved between pH 8 and 9 (Fig.
2C). At pH 10, the substrate RNA degraded.
The cleavage reaction was examined at various tempera-
tures in 30 mM HEPES/NaOH, pH 7.5, 20 mM MgCl2 and
150 mM NaCl for 1 h. The cleavage e⁄ciency was best at
30‡C (Fig. 2D). No speci¢c cleavage was observed at 55‡C.
Below 4‡C, however, about 20% cleavage was observed.
Finally, PB2 transcript (10 nmol) and 1 WM DNzPB2 (16)
were incubated for various periods at 37‡C in 30 mM HEPES/
NaOH, pH 7.5, 20 mM MgCl2 and 150 mM NaCl (Fig. 2E).
Under the conditions, the cleavage reaction increased with
incubation time.
3.2. Inhibition of in£uenza virus replication by DNA enzyme
Because our data indicated that antisense phosphothioate
oligonucleotides targeting AUG initiation codon sequences of
PB2 mRNA e¡ectively inhibited the in£uenza virus RNA
polymerase activity [9^11], and in£uenza virus replication in
infected cells [12^14] and mice [15], we tested the DNA en-
zyme which carries 10-23 catalytic sequence £anked with com-
plementary sequences around the AUG initiation codon of
PB2 mRNA (Table 1).
First, the inhibitory e¡ect on the concentration of oligonu-
cleotides was tested. MDBK cells were inoculated with in£u-
enza virus A/PR8/34 (moi = 0.1) at 4‡C for 1 h, and trans-
fected with 10, 5, 2.5, 1.25, 0.625 and 0.3125 WM of
oligonucleotides in 2% lipofectin at 34‡C for 4 h. At 20 h
after transfection (at 24 h after infection), the cells were har-
vested and the virus titer was measured by plaque-forming
assay on MDCK cells. The average percent virus titer of con-
trol MDBK cells without oligonucleotides as well as the stan-
dard deviation was calculated from three independent experi-
ments (Fig. 3). DNA enzyme, DNzPB2 (16), signi¢cantly
inhibited viral replication at 0.3 WM. At more than 0.6 WM,
however, both DNA enzymes, DNzPB2 (14) and DNzPB2
(16), signi¢cantly inhibited the replication of in£uenza virus.
Even a control oligonucleotide, DNzPB2 (C), inhibited viral
replication less than 50% at more than 2.5 WM. Antisense
phosphothioate oligonucleotides 20 and 28 nt long inhibited
viral replication less than 50% at more than 1 WM (Fig. 3B).
ODN PB2as (28) was slightly stronger than ODN PB2as (20).
At a high concentration (more than 5 WM), oligonucleotides
inhibited viral replication.
Next, at 1 WM of DNz and antisense phosphothioate oligo-
nucleotides, the inhibitory e¡ect on the challenged viral dose
was examined. MDBK cells were inoculated at a moi of 0.001,
0.01, 0.1, 1 and 10 and then treated as mentioned above (Fig.
4). When the moi was less than 1, 1 WM DNzPB2 (16) and
ODN PB2as (28) signi¢cantly inhibited viral replication.
Fig. 3. Dose-dependent inhibition of in£uenza virus replication by
DNA enzymes and antisense phosphothioate oligonucleotides.
MDBK cells were infected with in£uenza virus A/PR8/34 at a moi
of 0.1, and then transfected with the indicated concentration of oli-
gonucleotides (DNA enzymes (A) or antisense thio-oligonucleotides
(B)). The titer of the viruses was measured by plaque-forming assay
on MDCK cells. The average and standard deviation of % virus
yield were calculated from three independent experiments.
Fig. 4. The e¡ect of virus amount on inhibition by DNA enzymes
and antisense phosphothioate oligonucleotides. MDBK cells were in-
fected with in£uenza virus A/PR8/34 at the indicated moi, and then
transfected with 1 WM oligonucleotides (DNA enzymes (A) or anti-
sense thio-oligonucleotides (B)). The titer of the viruses was mea-
sured by plaque-forming assay on MDCK cells. The average and
standard deviation of % virus yield were calculated from three inde-
pendent experiments.
Table 1





aSequence of 10-23 DNA enzyme is shown in bold.
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When the moi was less than 0.1, 1 WM DNzPB2 (14) and
ODN PB2as (20) signi¢cantly inhibited viral replication.
When MDBK cells were transfected with DNA enzymes
¢rst and then infected with virus, no inhibition was observed
(data not shown). However, when the cells were transfected
with ODN PB2as (20) and ODN PB2as (28) ¢rst and then
infected with virus, viral replication was inhibited (data not
shown), which agreed with the previous results [12^14]. Some-
times the inhibitory e¡ect of oligonucleotides was a¡ected by
the lot of lipofectins (data not shown). Treatment of lipofectin
alone decreased the viral titers (data not shown). When cells
were incubated with 10 WM oligonucleotides without lipofec-
tin, no signi¢cant inhibition was observed (data not shown).
4. Discussion
In£uenza A virus contains eight single-stranded RNA seg-
ments of negative polarity as the genome and an RNA-depen-
dent RNA polymerase as a virion component. In£uenza A
virus RNA polymerase puri¢ed from in£uenza virus consists
of one part each of three subunits, PB1, PB2 and PA [19]. The
RNA polymerase catalyzes both transcription (the synthesis
of plus-strand mRNA containing the host cell-derived cap-I
structure at the 5P-terminus and poly(A) tail at the 3P-termi-
nus) and replication (the synthesis of full-length plus-strand
complementary RNA (cRNA) and the cRNA-dependent syn-
thesis of minus-strand viral RNA) [20,21]. In the infected
cells, mRNAs of viral RNA polymerase, NP and NS1 were
transcribed preferentially early on [20]. The amounts of
mRNAs of viral RNA polymerase subunits were the smallest
of all the viral mRNAs (T. Toyoda, unpublished data). This
evidence indicated that mRNAs of in£uenza virus RNA poly-
merase subunits (PB2, PB1 and PA) would be the best target
for inhibition of viral translation.
Antisense phosphothioate oligonucleotides with the target
AUG initiation codon sequences of in£uenza virus A/PR8/34
PB2 mRNA were shown to inhibit e¡ectively the viral repli-
cation in infected cells [12^14] and mice [15]. In order to test
the inhibitory e¡ect of DNA enzyme on the replication of
in£uenza virus in a cell culture system, we have synthesized
10-23 DNA enzyme £anked with the same target sequence of
PB2 mRNA.
DNA enzyme with longer arms (8-mer each) complementa-
ry to the target sequences cleaved the PB2 mRNA more e⁄-
ciently than that with shorter arms (7-mer each) (Fig. 1). The
longer one also inhibited viral replication more e⁄ciently than
the shorter one (Fig. 3). The cleavage reaction depended
mainly on MgCl2 concentration as previously reported [18].
However, DNzPB2 (16) showed maximum cleavage activity at
100 mM MgCl2 and at higher concentrations, the activity
slightly decreased (Fig. 2A). Not only MgCl2, but also NaCl
increased the activity (Fig. 2B). The optimal pH of the cleav-
age reaction was between 8 and 9 (Fig. 2C). The activity was
lost at high temperature (Fig. 2D). All of these results indicate
that the annealing condition of DNA enzyme and the sub-
strate RNA a¡ected the cleavage activity. A major concern
with DNA enzyme is that at the physiological MgCl2 concen-
tration (0.5^3.5 mM), the cleavage activity is lower than at
MgCl2 concentrations above 10 mM. In cultured cells,
DNzPB2 (16) inhibited in£uenza virus replication most e¡ec-
tively even at a high moi (Figs. 3 and 4).
From our results, one can conclude that RNA-cleaving
DNA enzyme inhibited in£uenza virus infection more e¡ec-
tively than the same amount of antisense phosphothioate oli-
gonucleotides (Figs. 3 and 4), although the cleaving activity
was shown to be low in physiological conditions. The poten-
tial toxicity of phosphothioate oligonucleotides may stem
from the release of sulfate [1]. Although we did not observe
any di¡erence in the cell numbers among the oligonucleotides
24 h after transfection (data not shown), DNA enzymes of
phosphodiester oligonucleotides seem to be less toxic than
phosphothioate oligonucleotides in vivo. Our data clearly in-
dicated that DNA enzyme is another promising agent for
control of viral infection.
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